Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Refractory, with Excess of Blasts × Podophyllotoxin × 30 days × Clear all

Sponsor

Interventions

Azacitidine 3 venetoclax 2 Vorinostat 2 Specimen Handling 2 Biopsy 2 thymoglobulin 1 fludarabine phosphate 1 fludarabine 1 decitabine and cedazuridine drug combination 1 cedazuridine 1 TAK-243 1 Rituximab 1 Melphalan 1 Levetiracetam 1 Lenalidomide 1 Injections 1 Idarubicin 1 Granulocyte Colony-Stimulating Factor 1 Gemtuzumab 1 Filgrastim 1 Decitabine 1 Cytarabine 1 Cyclophosphamide 1 Clinical Trials, Phase I as Topic 1 Busulfan 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡